Financhill
Back

PTC Therapeutics Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
43

PTCT
PTC Therapeutics

Last Price:
42.81
Seasonality Move:
30.95%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

PTC Therapeutics Price Quote

$42.81
+1.94 (+4.75%)
(Updated: November 6, 2024 at 2:35 PM ET)

PTC Therapeutics Key Stats

Sell
43
PTC Therapeutics (PTCT) is a Sell

Day range:
$39.89 - $41.08
52-week range:
$18.15 - $43.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.45
P/B ratio:
0%

Volume:
344.4K
Avg. volume:
806.9K
1-year change:
109.27%
Market cap:
$3.1B
Revenue:
$937.8M
EPS:
$-6.31

How Much Does PTC Therapeutics Make?

Is PTC Therapeutics Growing As A Company?

  • What Is PTC Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.13%
  • What Is PTC Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

PTC Therapeutics Stock Price Performance

  • Did PTC Therapeutics Stock Go Up Last Month?
    PTC Therapeutics share price went up by 16.44% last month
  • Did PTCT's Share Price Rise Over The Last Year?
    PTCT share price rose by 109.27% over the past 1 year

What Is PTC Therapeutics 52-Week High & Low?

PTC Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PTC Therapeutics?

  • How Much Debt Does PTC Therapeutics Have?
    Total long term debt quarterly is $284.8M
  • How Much Cash Does PTC Therapeutics Have?
    Cash and short term investments quarterly total is $1.1B
  • What Is PTC Therapeutics’s Book Value Per Share?
    Book value per share is -12.75

Is PTC Therapeutics Cash Flow Positive?

  • What Is PTCT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$115.5M
  • What Is PTC Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $870.9M
  • What Is PTC Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$304.9M

PTC Therapeutics Return On Invested Capital

Data Unavailable

PTC Therapeutics Earnings Date & Stock Price

PTC Therapeutics Competitors

  • Who Are PTC Therapeutics's Competitors?
    Below is a list of companies who compete with PTC Therapeutics or are related in some way:
    • BridgeBio Pharma Inc (BBIO)
    • Crinetics Pharmaceuticals Inc (CRNX)
    • Pfizer Inc (PFE)
    • Cassava Sciences Inc (SAVA)
    • Vertex Pharmaceuticals Inc (VRTX)

PTC Therapeutics Dividend Yield

PTC Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -33.65%
Revenue: -12.68% 3.14%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 6
Sell Recommendations: 1
Price Target: 41.50
Upside from Last Price: 1.54%

Major Shareholders

  • How many PTCT shares are owned by institutional investors?
    130.5M PTCT shares are owned by institutional investors
  • How many PTCT shares are owned by insiders?
    1.3M PTCT shares are owned by insiders